C110H118F8N30O14S2 — CID 165005389
N-[1-[2-[4-[(3R)-3-cyanopiperidin-1-yl]piperidin-1-yl]-2-oxoethyl]-3-[2-(difluoromethoxy)-5-ethylphenyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(oxan-4-yl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;methyl 4-[[1-[2-[3-[2-(difluoromethoxy)-5-ethylphenyl]-4-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)pyrazol-1-yl]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylate (PubChem CID 165005389) has the molecular formula C110H118F8N30O14S2 and a molecular weight of 2300.47 g/mol. Its IUPAC name is N-[1-[2-[4-[(3R)-3-cyanopiperidin-1-yl]piperidin-1-yl]-2-oxoethyl]-3-[2-(difluoromethoxy)-5-ethylphenyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(oxan-4-yl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;methyl 4-[[1-[2-[3-[2-(difluoromethoxy)-5-ethylphenyl]-4-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)pyrazol-1-yl]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylate.
| Compound Name | N-[1-[2-[4-[(3R)-3-cyanopiperidin-1-yl]piperidin-1-yl]-2-oxoethyl]-3-[2-(difluoromethoxy)-5-ethylphenyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(oxan-4-yl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;methyl 4-[[1-[2-[3-[2-(difluoromethoxy)-5-ethylphenyl]-4-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)pyrazol-1-yl]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 165005389 |
| Molecular Formula | C110H118F8N30O14S2 |
| Molecular Weight | 2300.47 g/mol |
| Exact Mass | 2298.88 |
| IUPAC Name | N-[1-[2-[4-[(3R)-3-cyanopiperidin-1-yl]piperidin-1-yl]-2-oxoethyl]-3-[2-(difluoromethoxy)-5-ethylphenyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfanylphenyl]-1-(oxan-4-yl)pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;methyl 4-[[1-[2-[3-[2-(difluoromethoxy)-5-ethylphenyl]-4-(pyrazolo[1,5-a]pyrimidine-3-carbonylamino)pyrazol-1-yl]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylate |
| SMILES | CCc1ccc(OC(F)F)c(-c2nn(CC(=O)N3CCC(CN4CCN(C(=O)OC)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)c1.CCc1ccc(OC(F)F)c(-c2nn(CC(=O)N3CCC(N4CCC[C@@H](C#N)C4)CC3)cc2NC(=O)c2cnn3cccnc23)c1.CSc1ccc(OC(F)F)c(-c2nn(C3CCOCC3)cc2NC(=O)c2cnn3cccnc23)c1.CSc1ccc(OC(F)F)c(-c2nn(CC(C)(C)O)cc2NC(=O)c2cnn3cccnc23)c1 |
| InChI | InChI=1S/C33H39F2N9O5.C32H35F2N9O3.C23H22F2N6O3S.C22H22F2N6O3S/c1-3-22-5-6-27(49-32(34)35)24(17-22)29-26(38-31(46)25-18-37-44-10-4-9-36-30(25)44)20-43(39-29)21-28(45)41-11-7-23(8-12-41)19-40-13-15-42(16-14-40)33(47)48-2;1-2-21-6-7-27(46-32(33)34)24(15-21)29-26(38-31(45)25-17-37-43-12-4-10-36-30(25)43)19-42(39-29)20-28(44)40-13-8-23(9-14-40)41-11-3-5-22(16-35)18-41;1-35-15-3-4-19(34-23(24)25)16(11-15)20-18(13-31(29-20)14-5-9-33-10-6-14)28-22(32)17-12-27-30-8-2-7-26-21(17)30;1-22(2,32)12-29-11-16(27-20(31)15-10-26-30-8-4-7-25-19(15)30)18(28-29)14-9-13(34-3)5-6-17(14)33-21(23)24/h4-6,9-10,17-18,20,23,32H,3,7-8,11-16,19,21H2,1-2H3,(H,38,46);4,6-7,10,12,15,17,19,22-23,32H,2-3,5,8-9,11,13-14,18,20H2,1H3,(H,38,45);2-4,7-8,11-14,23H,5-6,9-10H2,1H3,(H,28,32);4-11,21,32H,12H2,1-3H3,(H,27,31)/t;22-;;/m.0../s1 |
| InChIKey | IWPQFCGEBYSETP-HRRNSCMASA-N |
| XLogP | 16.33 |
| TPSA | 475.25 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 164 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2300.47 |
| LogP ≤ 5 | 16.33 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 39 |